Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort study

Arvid Engstrom,Victor Wintzell,Mads Melbye,Anders Hviid,Bjorn Eliasson,Soffia Gudbjornsdottir,Kristian Hveem,Christian Jonasson,Henrik Svanstrom,Bjorn Pasternak,Peter Ueda

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2022）

引用 5|浏览6

暂无评分

摘要

In this cohort study using nationwide data from three countries, use of SGLT2 inhibitors, compared with GLP-1 receptor agonists, was associated with a modestly reduced risk of new-onset AF.

查看译文

关键词

atrial fibrillation,sodium–glucose cotransporter,inhibitor treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要